DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

VIVUS, Inc.

NASDAQ: VVUS

14.82 0.32 (2.21%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $14.82 2.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.42
Previous Close $14.50
Daily Range $14.33 - $15.36
52-Week Range $9.86 - $31.21
Market Cap $1.5B
P/E Ratio -8.29
Dividend (Yield) $0.00 (0.0%)
Volume 3,715,693
Average Daily Volume 2,716,425
Current FY EPS -$1.91

Sector

Healthcare

Industry

Drugs

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website: http://www.vivus.com/

News & Commentary

The Top 3 Causes of Diabetes

Affecting more than 25 million people in the U.S., here are the primary factors that lead to this potentially debilitating disease and what's being done to curb its growth.

3 Humongous Health Care Stocks This Week

The major indexes might be tired after a great run this year, but these health-care stocks are sprinting ahead.

The 7 Least Obese U.S. States

A mixture of cultural and socioeconomic factors make these seven U.S. states the healthiest.

Vivus Heats Up, Shorts Discouraged On Possible Bidding War

Arena - Good Sales, Bad Sales, Long And Short

Bullish Two Hundred Day Moving Average Cross - VVUS

UPDATE: Dissident Holder First Manhattan Adds Three to Vivus Board Slate

Dissident Holder First Manhattan Adds 3 to Vivus Board Slate

First Manhattan Adds Alex Denner to Vivus Board Slate

Will Arena's Belviq Be The Next Anti-Obesity Drug To Make The Cover Of Time Magazine?

See More VVUS News...

VVUS's Top Competitors

VVUS $14.82 (2.21%)
Current stock: VVUS
PFE $29.04 (-0.24%)
Current stock: PFE
JNJ $86.82 (-0.45%)
Current stock: JNJ
RHHBY $65.96 (0.61%)
Current stock: RHHBY